Elucidating the specific pharmacological mechanism of action (MOA) of naturally taking place compounds is often hard. Even though Tarselli et al. (sixty) produced the 1st de novo synthetic pathway to conolidine and showcased this naturally transpiring compound properly suppresses responses to both equally chemically induced and inflammation-derived